GSE183041
Stable CDK12 knock-out ovarian cancer cells do not show an increased sensitivity to cisplatin and PARP inhibitor treatment
We stabily knock-out CDK12 in A2780 cell line and performed RNA-Seq profiling comparing WT and KO conditions. Overall design: We stabily knock-out CDK12 in A2780 cell line and performed RNA-Seq profiling comparing WT and KO conditions.